Instrument Inactif

Autres langues Astex Pharmaceuticals Inc

Actions

US04624B1035

Recherche biotechnologique et médicale

Cours en clôture Nasdaq
- ^USD	-

05/09/13

Dow Jones Industrial Average : Wall Street finit en petite hausse avant l'emploi

Autres langues

15/10/13	Astex Pharmaceuticals Inc : Astex Pharmaceuticals to Present at AACR-NCI-EORTC
11/10/13	Astex Pharmaceuticals Inc : Otsuka Pharmaceutical Completes Acquisition of Astex Pharmaceuticals
10/10/13	Astex Pharmaceuticals Inc : Astex Pharmaceuticals Responds to Further Misleading Claims Made by Sarissa Capital
09/10/13	Astex Pharmaceuticals Inc : Sarissa Capital Highlights Advancement Ofastex Pipeline Compound
08/10/13	Astex Pharmaceuticals Inc : Sarissa Capital Urges All Shareholders Of Astex Pharmaceuticals To Not Tender Their Shares At Current $8.50 Price
07/10/13	Astex Pharmaceuticals Inc : Astex Pharmaceuticals Announces Expiration of HSR Waiting Period for Pending Transaction
03/10/13	Astex Pharmaceuticals Inc : Astex Pharmaceuticals Issues Open Letter to Stockholders Regarding Otsuka Transaction
02/10/13	Astex Pharmaceuticals Inc : Sarissa Capital Issues Open Letter Regarding Astex Pharmaceuticals
09/09/13	Astex Pharmaceuticals Inc : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Astex Pharmaceuticals, Inc. Shareholders
07/09/13	Astex Pharmaceuticals Inc : Astex Pharmaceuticals Withdraws From Upcoming Investor Conferences
06/09/13	Astex Pharmaceuticals Inc : M & A Attorneys At Rigrodsky & Long, P.A. Announce Investigation Of Possible Inadequately Priced Astex Pharmaceuticals, Inc. Buyout
05/09/13	Astex Pharmaceuticals Inc : Law Offices of Howard G. Smith Announces Investigation of Astex Pharmaceuticals, Inc.
05/09/13	Astex Pharmaceuticals Inc : Law Firm Brower Piven Announces Investigation of Astex Pharmaceuticals, Inc. Proposed Acquisition
05/09/13	Astex Pharmaceuticals Inc : Komlossy Law, P.A. Announces Investigation of Astex Pharmaceuticals, Inc.
05/09/13	Astex Pharmaceuticals Inc : Finkelstein Thompson LLP Announces Investigation of Astex Pharmaceuticals, Inc. Buyout
05/09/13	Astex Pharmaceuticals Inc : Newman Ferrara LLP Announces Investigation of Astex Pharmaceutics, Inc.
05/09/13	Astex Pharmaceuticals Inc : Rigrodsky & Long, P.A. Announces Investigation Of Astex Pharmaceuticals, Inc. Buyout
05/09/13	Astex Pharmaceuticals Inc : Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Astex Pharmaceuticals Proposed Acquisition by Otsuka Holdings
05/09/13	Astex Pharmaceuticals Inc : Otsuka Pharmaceutical to Acquire Astex Pharmaceuticals for $8.50 Per Share in Cash
03/09/13	Astex Pharmaceuticals Inc : Astex Pharmaceuticals to Present at Investor Conferences in September
28/08/13	Astex Pharmaceuticals Inc : Astex Pharmaceuticals Announces Topline Results of SGI-110 AML Phase 2 Study
01/08/13	Astex Pharmaceuticals Inc : Astex Pharmaceuticals Reports 2013 Second Quarter Financial Results
29/07/13	Astex Pharmaceuticals Inc : Astex Pharmaceuticals to Announce 2013 Second Quarter Financial Results on August 1st
22/07/13	Astex Pharmaceuticals Inc : Astex Pharmaceuticals Announces First Data Showing Early Combination Treatment of HSP90 Inhibitor AT13387 With Targeted Agents Delays Emergence of Resistance in Preclinical Models
08/07/13	Astex Pharmaceuticals Inc : Astex Pharmaceuticals Announces IND Candidate: ASTX727 a Potential Best-in-Class Oral Hypomethylator